4//SEC Filing
Kaba Samer 4
Accession 0001267602-20-000043
CIK 0001267602other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:10 PM ET
Size
6.5 KB
Accession
0001267602-20-000043
Insider Transaction Report
Form 4
Kaba Samer
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2020-03-09$6.13/sh−838$5,137→ 4,834 total - Tax Payment
Common Stock
2020-03-10$5.63/sh−838$4,717→ 3,996 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of Restricted Stock Units. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock unit award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c).
- [F2]Actual purchase prices ranged from $5.5900 to $5.6500.
Documents
Issuer
ALIMERA SCIENCES INC
CIK 0001267602
Entity typeother
Related Parties
1- filerCIK 0001773634
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:10 PM ET
- Size
- 6.5 KB